Advisory Research’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-27,185
Closed -$974K 319
2020
Q3
$974K Sell
27,185
-9,951
-27% -$357K 0.09% 179
2020
Q2
$898K Buy
37,136
+13,360
+56% +$323K 0.08% 182
2020
Q1
$416K Buy
+23,776
New +$416K 0.03% 212